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In previous reports (1—3) it was shown that the hista-
minesensitivity of animals and man may he decreased by 
treatment with histamine over a period of 7 to 10 days. La-
ter (4—6) it was shown that histamine- and anaphylactic 
shock in guinea pigs could be prevented by pretreatment 
with histamine. The question of how to account for the in-
creased resistance to histamine demonstrated by these ex-
periments naturally arises, it seemed very probable that the 
beneficial effects of the pretreatment with histamine might 
he attributed to the increased activity of the enzyme hista-
uiinase. This enzyme, discovered by Best and McHenry (7, 8). 
lias the specific property ol destroying histamine and is con-
stantly present in the different organs of the living animal. 
It seemed possible that treatment with histamine might in-
crease the histaminase-content of the organs. 
The following experiments were carried out in order to 
determine what effect, if any, pretreatment with histaminasc 
might liuve on histamine- and anaphylactic shock in guinea 
pigs-
EXPERIMENTS 
1. Thirty male guinea pigs weighing 200 to 230 grams 
were used in this experiment. In 20 animals the jugular vein 
was exposed under slight ether-narcosis and injected with 3 
ampules of Torantil ( I 360)' dissolved in 2 ml. of phvsiolo-
/ 
1 Torautil (T 3(10) i« a histaminase preparat ion of the Winthrop 
Chemical Co A unit of histaminase is the amount uecessaxy to detoxify 
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gical saline. After 15 minutes wlien the guinea pigs had 
entirely recovered, from the narcosis and behaved in every 
respect as the 10 normal controls, all, 30 animals (the pretreated 
as well as the non-pretreated controls) were given 4 mgni. of 
histamine base as histamine dihydrochloride intraabdomi-
nally. 
The results may be summarized as follows: Within 3 to 
5 minutes all of the 10 non-pretreated control animals showed 
symptoms of histamine-shock which reached a maximum in 
5 to 7 minutes; 7 of these animals died. In the 20 guinea pigs 
pretreated with histaminase there were no signs of shock 
during the period when the control animals exhibited symp-
toms. After 12 to 15 minutes 6 of (he 20 animals showed slight 
dyspnea which in another 5 io 10 minutes decreased in all 
but 2 of the 6 animals. These 2 animals later developed a 
real histamine-shock and died 35 minutes after the injection. 
These results show that histaminase injected intravenously 
has a very definite effect in vino on histamine-shock. Of the 
10 controls all developed severe shock. 7 died ; of the 20 
pretreated animals, 4 developed slight shock much later than 
the controls and only 2 died. 
2. Thirty 200 to 250 gram male guinea pigs were sensi-
tized with 3 ml. of 50 per cent egg-white sujbcufcaneously. Two 
to three weeks later 20 of the 30 animals were injected with 
histaminase intrajugularly under the same conditions and 
using the same amount as in the first experiment. The 10 
control animals received no treatment. Fifteen minutes 
following ilie injection of histaminase, all animals received 
2 ml. of 50 per cent eggwhite intraabdominally. 
The result were similar to those of histamine-shock. In 
the control group symptoms of anaphylactic shock began 
.within 4 to 5 minutes in all of the animals. The shock became 
very severe, with a maximum 10 minutes after tlie shocking 
dose' of egg-white was administered, and continued for ^ to 
1 hour. Four animals died after 10 to 14 minutes. Iu the 
pretreated group of 20 animals, no symptoms were apparent 
one mg of histamine dihydrochloride. One ampule of T—360 contains one 
,H. D. (Histamine—destroying) unit. This material was supplied through 
the courtesy of Dr. H. A. Care, the Department of Medical Research, 
Winthrop Chemical Company. 
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during the first 20 minutes; after 20 minutes, 5 of the animals 
showed slight symptoms such as scratching of nose, ex-
citement. etc., which lasted for only a few minutes. No other 
signs of anaphylaxis were observed and none of the animals 
died. 
The objective symptoms observed in both experiments < 
on histamine and anaphylactic shock may be compared as 
follows: In the control animals of both experiments the 
temperature fell from the average normal of 37.5 to 38°C. to 
30 to 51°C. during the first 6 to 8 minutes. In the animals 
pretreated with histaminase in both experiments there was 
no such marked fall; however six of the animals showecf a 
slight drop of to 1°C., 13 to 15 minutes after the liistamine-
injection, with a continued drop to 31 to 51.5°C. in the two 
animals that finally died in the experiment on injection of 
histamine. At necropsy, pulmonary emphysema was noted 
in all controls and in the pretreated group only in the two 
animals which died of histaminc-shock. 
3. Six male guinea pigs weighing 200 to 250 grams were 
used in this experiment. Three animals previously sensitized 
to eggwhite in the same manner as described in the second 
experiment together with three non-sensitized animals were 
prepared for intrajugular injection of histaminase as pre-
viously described. Inactivation of the histaminase was ac-
complished by heating in a waterbath at 65°C. for 10 minutes 
(8). Each animal received 5 ampules of the histaminase as in 
the other experiments. After 15 minutes the shocking dose 
of 2 ml. 50 per cent egg-white solution was given intraabdo-
minally to 5 sensitized animals and 4 mgm. of the histamine 
base were given iniraabdominally to each of a second group 
of 3 animals. 
Syintoms of anaphylactic and histamine-shock appeared 
within 4 to 5 minutes as in the controls of the first two expe-
riments. The symptoms were very marked and severe, more 
so than in the control group, and the shock rapidly progres-
sed and culminated in all cases in death of the animals 
within 10 minutes. Apparently the injection of the inactiva-
ted histaminase served to aggravate and increase the sympr 
toms of shock. . i 
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DISCUSSION 
The purpose of the experiments just described was to 
provide an experimental basis for the recent successful ad-
ministration of histaminase (T 560) in the treatment of 
disorders based on release of histamine: physical allergy (9, 
10) serum-sickness (1.1) hay-fever (12) bronchial asthma (15), 
inasmuch as such successful results are contrary to what 
might be expected from the studies of Best and McHcnry on 
histaminase. " . 
According to these authors the i»activation of histamine 
by histaminase even under optimal, conditions (37nC., pH 
7.2) requires several hours and is complete only, alter 24 
hours. If so, the administration of histaminase as a therapeu-
tic measure is not justified. How could one, for instance, 
explain the results of Roth and Horton (9, 10) who were able 
to prevent the symptoms of a physical allergy (cold-super-
fiensitiveness) which would ordinarily occur on the immersion 
of the hands and arms of the patient in ice-cold water, by a 
previous administration of histaminase? According to the ex-
periments of Best and McHcnry, it would take hours for the 
histaminase present in the blond to destroy the released his-
tamine and before it could be destroyed local and systemic 
reactions could occur. 
'.The same objection may be raised in the case of treat-
ment with histamine even if the histaminase-content of the 
organism is increased by pretreatment with histamine, such 
an increase could have no influence in the appearance of 
allergic symptoms since the histamine suddenly released, 
which produces the symptoms, could be destroyed by the 
histaminase only after hours. * 
On the basis of the results of clinical investigations 
then, one must suppose that the. histaminase in vivo acts 
differently than in viiro, i. e., without the necessary in vitro 
incubationary period. If this is so the histaminase-treatment 
of allergy, is. rational, but if such is not the case, then the 
successful results reported must be ascribed merely to 
accident or to some unknown factors and until such factors 
are discovered the administration of histaminase would on a 
theoretical basis be unwarranted. 
We believe that our experiments afford evidence sup-
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porting the therapeutic use of histaminase and indicate that 
it acts apparently more rapidly in vino than in vitro. This 
is in accordance with the recent, results of Takebayashi (14!. 
Experiments on the guinea pig (15) have shown that a 
mild alarm-reaction elicited by exposure to some damaging 
agent decreased the anaphylactic response of sensitized 
guinea pigs. One might suppose that the intravenous injection 
of 3 ampules of histaminase might be sufficient to act as it-
damaging agent and thus increase the nonspecific resistance 
of the organism. That this-objection is not valid is shown by 
the third experiment in which inactivated histamine was 
injected with no beneficial effect on anaphylactic or hista-
mine-shock. 
At the beginning of ou,r experiments we believed that 
the effect of the histamine-treatment was due io an increase 
in the histaminase-content of the blood and 1 issues. However 
recent investigations by Rose el nl. (16) have shown that 
there is no increase in the histaininasc-content of rat tissues 
after pretreatmeut \vi111 histamine. Explanation of the good 
effects of histanune-pretreatment must be found in some 
other mechanism. It has been shown (2. 17) thai an important 
feature of histamine shock, the decrease.in blood-volume, 
not only does not occur after histaiiiine-pretreatment, but the 
organism actually responds with a marked increase of blood 
volume. This reverse response cannot merely be due to an 
increased rate of destruction of histamine, such as might be 
caused by an increased histaminase-content of the tissues, 
but represents, rather a difference in> response to histamine 
itself. Such an altered response of the blood vessels for 
example has been shown (5) also in experiments involving 
acute reactions (tachyphylaxis). 
SUMMARY ' ; 
1. In guinea pigs, the intravenous injection of histaminase 
i5 minutes before the intraabdominal injection of 4 mgm. of 
histamine prevented in most instances the symptoms of his-
tamine shock. Of 10 control animals, all showed marked 
symptoms within 5 to 7 minutes and 7 animals died shortly af-
ter. Ofthe 20 animals pretreated with histaminase, 6 showed 
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slight symptoms after 15 minutes, wdiich disappeared in a 
few minutes in all but 2 animais tliat died 55 minutes after 
the injection of the histamine. 
2. Histaminase given intravenously 15 minutes before 
the administration of egg-white intruabdominally to previ-
ously sensitized guinea pigs prevented an anaphylactic shock 
completely in 15 out of 20 animals. The other 5 guinea, pigs 
showed only very slight symptoms beginning 20 minutes af-
ter the injection of egg-w7hite and lasting for a few minutes. 
Of the 10 control animals all showed severe anaphylactic 
shock developing within 5 to 10 minutes and 4 animals died 
10 to 14 minutes after the injection of the egg-wrhite. 
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